Dihydroartemisinin was reported to decrease iron uptake and disturb iron homeostasis in cancer cells through down regulating cell-surface transferrin receptor-1, which may be a novel mechanism of dihydroartemisinin independent of oxidative damage that has been previously mentioned as anticancer property of artemisinin [163]. This evidence concerns the gene TFRC and cancer.